Recent advances and applications of semiconducting polymer nanomaterials in cancer therapy

In the era of precision medicine for cancer treatment, the rational design of nanoparticles with responsive characteristics is crucial for the release of payloads at target sites. At tumor sites, internal triggers such as pH, enzymes, and redox conditions are often used to activate drugs. However, some internal triggers may vary due to pathological conditions and might be insufficient to effectively activate nanoparticles. Additionally, these internal triggers can also be activated in normal tissues, which motivates the design of therapeutic agents that respond to external stimuli. Compared to endogenous stimuli, external stimuli such as light, ultrasound, and X-rays offer greater flexibility, enabling controlled drug delivery in a specific and precise manner and providing an ideal approach to reduce systemic toxicity. Semiconducting polymer nanoparticles (SPNs), derived from π-conjugated polymers, possess optical, chemical, and biological properties, allowing them to efficiently convert near-infrared (NIR) light, ultrasound, and X-ray energy into heat or singlet oxygen ( 1 O 2 ), thereby inducing immunogenic therapy. By covalently conjugating SPNs with therapeutic agents, 1 O 2 -activatable SPN-based therapeutic agents can be constructed to achieve targeted delivery and on-demand release of therapeutics. Here, we summarize recent advancements in SPNs based nanomedicines stimulated by NIR light, ultrasound, and X-rays for photothermal therapy (PTT), photodynamic therapy (PDT), sonodynamic therapy (SDT), and radiodynamic therapy (RDT) in cancer treatment. We discuss in detail the combination therapies achieved by loading or conjugating SPNs with other therapeutic elements, such as chemotherapeutic drugs and immunotherapeutic agents. Furthermore, we address the potential challenges and clinical translation prospects of SPNs in biomedical applications. • This review covers recent advances in cancer therapy using semiconducting polymer nanoparticles (SPNs) • This review focuses on engineering strategies of SPNs for precise cancer therapy via controllable spatiotemporal properties. • This review provides new ideas for designing external stimuli responsive nanosystems and inspires their future biomedical applications.

Authors

Institutions

Publication Details

Journal
Precision medicine and engineering.
Published
2025-11-26
DOI
https://doi.org/10.1016/j.preme.2025.100052
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recent advances and applications of semiconducting polymer nanomaterials in cancer therapy

Ling Ding, Jingyang Su, Jingchao Li, Renfu Li
Precision medicine and engineering.
Nanoplatforms for cancer theranostics
article

Recent advances and applications of semiconducting polymer nanomaterials in cancer therapy

Ling Ding, Jingyang Su, Jingchao Li, Renfu Li
article en

Abstract

In the era of precision medicine for cancer treatment, the rational design of nanoparticles with responsive characteristics is crucial for the release of payloads at target sites. At tumor sites, internal triggers such as pH, enzymes, and redox conditions are often used to activate drugs. However, some internal triggers may vary due to pathological conditions and might be insufficient to effectively activate nanoparticles. Additionally, these internal triggers can also be activated in normal tissues, which motivates the design of therapeutic agents that respond to external stimuli. Compared to endogenous stimuli, external stimuli such as light, ultrasound, and X-rays offer greater flexibility, enabling controlled drug delivery in a specific and precise manner and providing an ideal approach to reduce systemic toxicity. Semiconducting polymer nanoparticles (SPNs), derived from π-conjugated polymers, possess optical, chemical, and biological properties, allowing them to efficiently convert near-infrared (NIR) light, ultrasound, and X-ray energy into heat or singlet oxygen ( 1 O 2 ), thereby inducing immunogenic therapy. By covalently conjugating SPNs with therapeutic agents, 1 O 2 -activatable SPN-based therapeutic agents can be constructed to achieve targeted delivery and on-demand release of therapeutics. Here, we summarize recent advancements in SPNs based nanomedicines stimulated by NIR light, ultrasound, and X-rays for photothermal therapy (PTT), photodynamic therapy (PDT), sonodynamic therapy (SDT), and radiodynamic therapy (RDT) in cancer treatment. We discuss in detail the combination therapies achieved by loading or conjugating SPNs with other therapeutic elements, such as chemotherapeutic drugs and immunotherapeutic agents. Furthermore, we address the potential challenges and clinical translation prospects of SPNs in biomedical applications. • This review covers recent advances in cancer therapy using semiconducting polymer nanoparticles (SPNs) • This review focuses on engineering strategies of SPNs for precise cancer therapy via controllable spatiotemporal properties. • This review provides new ideas for designing external stimuli responsive nanosystems and inspires their future biomedical applications.

Precision medicine and engineering.Vol. 3(1)
Donghua University (CN), China Medical University (CN)
Openalex Percentile: Top 64%
Nanoplatforms for cancer theranostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.